WHIPPANY, N.J. — Bayer has rolled out a TENS device under its Aleve pain relief brand, called Aleve Direct Therapy.

The company said the back pain product is now available in the analgesics aisle at retailers nationwide. Devices using TENS (transcutaneous electrical nerve stimulation) technology alleviate pain by sending pulses on the surface of the skin and along nerves.

The stimulation from the pulses helps prevent pain signals from reaching the brain as well as prompts the body to produce higher levels of its own painkillers, or endorphins.

Bayer noted that the deep penetrating relief brought by Aleve Direct Therapy’s patented waveform technology provides a noninvasive, drug-free way to control pain.

“For people suffering from lower back pain, the availability of the Aleve Direct Therapy TENS device is good news. The device provides drug-free, deep penetrating lower-back pain relief, without a prescription,” stated Fred Duchin, vice president of marketing analgesics of cough and cold, cardiovascular, for Bayer’s consumer health division.

Aleve Direct Therapy is indicated for the temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities. The Food and Drug Administration-approved product is regulated as a Class II medical device.

“Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to visit the doctor. It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs,” commented Andre Schmidt, vice president of U.S. medical affairs in the Bayer consumer health division. “We are pleased to be able to provide this safe, drug-free and convenient self-care option to help consumers get the relief they need from lower back pain.”